Michael P. Chu - Concepedia

Author

Michael P. Chu

Also Known As

Jonathan Abele, M.P. Chu, Matthew Lunning, Michael P. Chu, Michael Chu, Michael P Chu, Michael P. Chu, Michael Patvin Chu, Michael W. A. Chu, Michael P. Chu

127

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

University of Alberta Princess Margaret Cancer Centre University of Calgary Memorial Sloan Kettering Cancer Center McGill University Health Centre

About

Michael P. Chu is an author at University of Alberta specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	16	725
2	Health Sciences	5	5	162
3	Natural Sciences	1	1	14
4	Public Health	1	1	44
5	Allergy	1	1	15

Michael P. Chu

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Cyclophosphamide-Induced Cardiomyopathy Sumandeep Dhesi, Michael P. Chu, Gregg Blevins, Journal of Investigative Medicine High Impact Case Reports Translational MedicineHeart FailureCardiomyopathyCardiogenic ShockCardiovascular Disease	2013	130
Elranatamab in relapsed or refractory multiple myeloma: the MagnetisMM-1 phase 1 trial Nizar J. Bahlis, Caitlin Costello, Noopur Raje, Nature Medicine	2023	122
MS4A4A: a novel cell surface marker for M2 macrophages and plasma cells Ratna Sanyal, Maria J. Polyak, Jonathan Zuccolo, Immunology and Cell Biology	2017	106
Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer Michael P. Chu, J. Randolph Hecht, Dennis J. Slamon, JAMA Oncology	2016	105
Gastric Acid Suppression Is Associated With Decreased Erlotinib Efficacy in Non–Small-Cell Lung Cancer Michael P. Chu, Sunita Ghosh, Carole Chambers, Clinical Lung Cancer Decreased Erlotinib EfficacyNon–small-cell Lung CancerOncologyGastrointestinal OncologyMedicine	2014	101
Skeletal muscle density is an independent predictor of diffuse large B‐cell lymphoma outcomes treated with rituximab‐based chemoimmunotherapy Michael P. Chu, Jessica Lieffers, Sunita Ghosh, Journal of Cachexia Sarcopenia and Muscle	2016	83
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma Yaël C. Cohen, Hila Magen, Moshe E. Gatt, New England Journal of Medicine	2025	70
Concomitant Administration of Proton Pump Inhibitors and Capecitabine is Associated With Increased Recurrence Risk in Early Stage Colorectal Cancer Patients Julia Sun, Alastair Ilich, Christina Kim, Clinical Colorectal Cancer OncologyMedicineGastroenterologyColorectal CancerProton Pump Inhibitors	2015	59
Body composition is prognostic and predictive of ipilimumab activity in metastatic melanoma Michael P. Chu, Yuetong Li, Sunita Ghosh, Journal of Cachexia Sarcopenia and Muscle	2020	56
Skeletal Muscle Radio-Density Is an Independent Predictor of Response and Outcomes in Follicular Lymphoma Treated with Chemoimmunotherapy Michael P. Chu, Jessica Lieffers, Sunita Ghosh, PLoS ONE Oncologic ImagingPathologyImmunotherapyLow SmdRadiation Medicine	2015	56

Page 1